No Data
No Data
Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025
Organogenesis Holdings Leads These 3 US Penny Stocks
The Colossal Foundation Donates $1.5M to the Wyss Institute at Harvard University to Advance Artificial Womb Technology for Wildlife Conservation
Organogenesis Files to Sell 130K Shares of Common Stock for Holders
Insider Sale: President and CEO of $ORGO (ORGO) Sells 18,416 Shares
Morgan Stanley Initiates Organogenesis(ORGO.US) With Hold Rating, Announces Target Price $4